Fetal damage in diabetic mother in 1st trimester is best assessed by :
**Core Concept**
The underlying principle being tested is the assessment of fetal damage in diabetic mothers during the first trimester. This involves understanding the effects of maternal diabetes on fetal development and the role of various diagnostic tools in evaluating fetal health.
**Why the Correct Answer is Right**
In diabetic mothers, the risk of fetal damage is highest in the first trimester due to the teratogenic effects of hyperglycemia. The correct answer assesses the level of fetal damage by measuring the level of alpha-fetoprotein (AFP) in maternal serum. Elevated levels of AFP indicate an increased risk of neural tube defects (NTDs) and other fetal anomalies. This is because AFP is a protein produced by the yolk sac and fetal liver, and its levels are significantly higher in the presence of NTDs. The measurement of AFP is a critical component of first-trimester screening for fetal anomalies in diabetic mothers.
**Why Each Wrong Option is Incorrect**
**Option A:**
This option is incorrect because it does not specifically address the assessment of fetal damage in diabetic mothers during the first trimester. While ultrasound is a valuable tool in fetal assessment, it is not the best method for evaluating fetal damage in diabetic mothers during the first trimester.
**Option B:**
This option is incorrect because it does not directly assess fetal damage. Cardiotocography (CTG) is a tool used to monitor fetal heart rate and assess fetal well-being, but it does not provide information on fetal damage.
**Option C:**
This option is incorrect because it is not specific to fetal damage in diabetic mothers. Fetal echocardiography is a valuable tool in assessing fetal cardiac anatomy, but it is not the best method for evaluating fetal damage in diabetic mothers during the first trimester.
**Clinical Pearl / High-Yield Fact**
In diabetic mothers, the risk of fetal damage is highest in the first trimester, and elevated levels of alpha-fetoprotein (AFP) in maternal serum are a critical indicator of increased risk of neural tube defects (NTDs) and other fetal anomalies.
**Correct Answer:** A. Measurement of maternal serum alpha-fetoprotein (AFP).